BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37564981)

  • 1. Case Report: Aggressive neural crest tumors in a child with familial von Hippel Lindau syndrome associated with a germline
    Landen L; De Leener A; Le Roux M; Brichard B; Aydin S; Maiter D; Lysy PA
    Front Endocrinol (Lausanne); 2023; 14():1204793. PubMed ID: 37564981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
    Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
    Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
    Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
    Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings.
    Fugaru I; Goudie C; Capolicchio JP
    Fam Cancer; 2022 Apr; 21(2):229-233. PubMed ID: 33877494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.
    Hasani-Ranjbar S; Amoli MM; Ebrahim-Habibi A; Haghpanah V; Hejazi M; Soltani A; Larijani B
    Fam Cancer; 2009; 8(4):465-71. PubMed ID: 19649731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees.
    Qi XP; Liu WT; Li JY; Dai Y; Ma JM; Zhao Y; Fei J; Li F; Shen M; Jin HY; Chen ZG; Du ZF; Chen XL; Zhang XN
    Mol Med Rep; 2013 Sep; 8(3):799-805. PubMed ID: 23842656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.
    Vérot PL; Rabattu PY; Chabre O; Gayot A; Sartelet H; Faguet R; Robert Y; Piolat C
    Arch Pediatr; 2020 Nov; 27(8):497-501. PubMed ID: 33067065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
    Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
    Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
    Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.
    Abbott MA; Nathanson KL; Nightingale S; Maher ER; Greenstein RM
    Am J Med Genet A; 2006 Apr; 140(7):685-90. PubMed ID: 16502427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.
    Gergics P; Patocs A; Toth M; Igaz P; Szucs N; Liko I; Fazakas F; Szabo I; Kovacs B; Glaz E; Racz K
    Eur J Endocrinol; 2009 Sep; 161(3):495-502. PubMed ID: 19574279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
    JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.